SPHD - ETF AI Analysis

Top Page

Invesco S&P 500 High Dividend Low Volatility ETF (SPHD)

Rating:69Neutral

Price Target:―

SPHD, the Invesco S&P 500 High Dividend Low Volatility ETF, earns a solid overall rating driven by strong, income-focused holdings like Verizon and Bristol-Myers Squibb, which combine healthy cash flows, attractive dividends, and supportive long-term growth strategies. Additional support comes from stable names such as Pfizer, UPS, and major REITs like Host Hotels & Resorts and Simon Property Group, though weaker holdings like Conagra Brands and Healthpeak Properties, with profitability and technical challenges, modestly weigh on the fund. The main risk is its concentration in high-dividend, often highly leveraged sectors such as telecom, real estate, and mature consumer businesses, which can be sensitive to interest rates and sector-specific headwinds.

Positive Factors

Stable, Income-Focused Holdings

Many of the largest positions are in established dividend-paying companies, which can provide a steadier income stream for investors.

Defensive Sector Tilt

Heavy exposure to traditionally defensive areas like real estate, consumer defensive, utilities, and health care can help cushion the fund during market downturns.

Solid Asset Base

The fund’s multibillion-dollar asset size suggests it is well-established and likely to offer good trading liquidity for everyday investors.

Negative Factors

Sector Concentration Risk

Large weights in real estate and other defensive sectors mean the fund could be hurt if these specific areas of the market struggle.

Mixed Performance Among Top Holdings

Some key positions have shown weak or negative recent performance, which can drag on the ETF’s overall returns.

Limited Geographic Diversification

With almost all assets in U.S. companies, the fund offers little protection if the U.S. market faces broad challenges.

SPHD vs. SPDR S&P 500 ETF (SPY)

AUM3.59B

RegionNorth America

Expense Ratio0.30%

Beta0.37

IssuerInvesco

Inception DateOct 18, 2012

Dividend Yield3.97%

Asset ClassEquity

Index TrackedS&P 500 Low Volatility High Dividend Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume855,741

30 Day Avg. Volume909,389

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

54.19

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering49

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SPHD Summary

SPHD is an ETF that follows the S&P 500 Low Volatility High Dividend Index, focusing on U.S. large companies that pay relatively high dividends and have had smoother price moves in the past. It holds well-known names like Pfizer and Verizon, along with many real estate, utility, and consumer defensive companies. Someone might invest in SPHD to seek regular income from dividends and a somewhat steadier ride than the overall stock market, while still staying diversified across many sectors. A key risk is that it can still lose value when the stock market falls, and its focus on dividend stocks may lag in fast-growth markets.

How much will it cost me?The expense ratio for SPHD is 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average for ETFs because SPHD is designed to track a specialized index focusing on high dividends and low volatility, requiring more active management. It’s a good option for investors seeking steady income and reduced risk.

What would affect this ETF?SPHD could benefit from stable economic conditions and low interest rates, which often support high-dividend sectors like Real Estate and Utilities. However, rising interest rates or economic downturns may negatively impact these sectors, as they tend to be sensitive to borrowing costs and consumer spending. Additionally, regulatory changes in healthcare or energy could influence the performance of its top holdings.

SPHD Top 10 Holdings

SPHD is leaning heavily on steady, dividend-rich U.S. names, with real estate, consumer defensive, and utilities setting the tone. Realty Income and Host Hotels are helping to pull the fund forward, while UPS has been a quiet workhorse with rising momentum. In health care, Pfizer and Bristol-Myers are more mixed, offering stability but not much fireworks. On the weaker side, Conagra looks stuck in the mud and Verizon has been dragging, reminding investors that high yield doesn’t always mean smooth sailing.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
PFE	Pfizer	3.08%	$111.94M	$150.33B	-0.30%	74 Outperform
MO	Altria Group	3.03%	$110.12M	$104.06B	18.69%	64 Neutral
UPS	United Parcel	2.84%	$103.24M	$90.12B	-7.01%	72 Outperform
CAG	Conagra Brands	2.73%	$99.04M	$8.85B	-28.50%	52 Neutral
VZ	Verizon	2.70%	$98.05M	$187.72B	13.02%	81 Outperform
DOC	Healthpeak Properties	2.62%	$95.22M	$12.24B	-16.55%	58 Neutral
BMY	Bristol-Myers Squibb	2.53%	$91.71M	$112.07B	-6.62%	78 Outperform
SPG	Simon Property	2.51%	$91.13M	$62.46B	10.04%	70 Outperform
HST	Host Hotels & Resorts	2.45%	$88.94M	$12.74B	10.89%	77 Outperform
O	Realty Income	2.44%	$88.62M	$56.26B	11.93%	70 Outperform

SPHD Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

48.18

Positive

100DMA

48.00

Positive

200DMA

47.34

Positive

Market Momentum

MACD

0.50

Negative

RSI

70.08

Negative

STOCH

71.96

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SPHD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 48.93, equal to the 50-day MA of 48.18, and equal to the 200-day MA of 47.34, indicating a bullish trend. The MACD of 0.50 indicates Negative momentum. The RSI at 70.08 is Negative, neither overbought nor oversold. The STOCH value of 71.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SPHD.

SPHD Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SPHD	―	―	$3.59B	0.30%	―
MGC	―	―	$9.98B	0.07%	―
PRF	―	―	$8.89B	0.34%	―
QYLD	―	―	$8.36B	0.61%	―
QQQI	―	―	$8.30B	0.68%	―
FTCS	―	―	$8.22B	0.52%	―

Performance Comparison

SPHD

Invesco S&P 500 High Dividend Low Volatility ETF

50.28

3.64

7.80%

MGC

Vanguard Mega Cap ETF

―

PRF

Invesco FTSE RAFI US 1000 ETF

―

QYLD

Global X NASDAQ 100 Covered Call ETF

―

QQQI

NEOS Nasdaq 100 High Income ETF

―

FTCS

First Trust Capital Strength ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents